China is experiencing a surge in respiratory illnesses, notably human metapneumovirus (HMPV), alongside other viruses such as Influenza A, Mycoplasma pneumoniae, and COVID-19. This increase has led to overcrowded hospitals, particularly affecting children and the elderly.
HMPV is a common respiratory virus causing upper respiratory infections similar to a cold. It typically occurs in winter and early spring, affecting individuals of all ages but posing higher risks to young children, older adults, and those with weakened immune systems.
In response to the situation in China, India's Directorate General of Health Services (DGHS) has stated there is no cause for alarm domestically. Analysis of respiratory outbreak data in India shows no substantial increase in cases for December 2024. The DGHS advises the public to follow standard precautions to prevent the spread of respiratory infections.
China's foreign ministry has downplayed the severity of the outbreak, stating that current respiratory disease cases are less severe compared to the previous year and asserting that it is safe for travel within the country.
The World Health Organization (WHO) has not issued any formal advisories or alerts regarding the HMPV situation in China. Health authorities continue to monitor the situation closely.
For a visual overview of the situation, you can watch the following video:
ET Online
TOI News Desk